Skip to content

Zero-P and plate-cage: a clinical study of two ACDF procedures for the treatment of cervical spondylosis

Zero-P and plate-cage: a clinical study of two ACDF procedures for the treatment of cervical spondylosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047197
Enrollment
Unknown
Registered
2021-06-10
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylosis

Interventions

Experimental group1:Zero-P
Experimental group2:plate-cage

Sponsors

Tongji Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who can be clearly diagnosed as cervical spondylosis based on symptoms, signs, and imaging examinations; 2. Patients who are ineffective after conservative treatment, seriously affect their life and work, and require surgical treatment; 3. No gender limit, aged 18 to 80 years; 4. Patients who agree to surgery and regular follow-up visits and who can meet the needs of this study; 5. Those who agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from severe posterior longitudinal ligament ossification or severe osteoporosis; 2. Patients with Diffuse Idiopathic Skeletal Hyperostosis (Diffuse Idiopathic Skeletal Hyperostosis, DISH) and Ankylosing Spondylitis (AS); 3. Patients who have undergone severe degeneration in the adjacent segments of the preoperative responsible segment; 4. Patients with severe complications before surgery; 5. Patients with chronic cardiovascular and cerebrovascular diseases such as myocardial infarction, cerebral infarction and cerebral hemorrhage 6. Patients with a history of cervical spine surgery; 7. Metal allergy, allergic physique or allergy to multiple drugs; 8. Accompanied by spinal tumors or infections and other diseases; 9. Have severe bleeding tendency or coagulation dysfunction; 10. Pregnant or lactating women and those who are contraindicated in imaging examinations; 11. Mental or cognitive impairment; 12. The researcher believes that it is inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Pain visual analog scale;Cervical curvature;

Countries

China

Contacts

Public ContactYu Yan

Tongji Hospital of Shanghai

yuyan_83@hotmail.com+86 13918096186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026